These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6017141)

  • 1. Long-term efficacy of oil-adjuvant influenza vaccine in an industrial population.
    Howell RW
    Br J Ind Med; 1967 Jan; 24(1):66-70. PubMed ID: 6017141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination--acceptance in an industrial population.
    Smith JW; Pollard R; Fletcher WB; Barker R; Lewis JR
    Br J Ind Med; 1974 Oct; 31(4):292-7. PubMed ID: 4425631
    [No Abstract]   [Full Text] [Related]  

  • 3. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated influenza vaccines: pre-vaccination haemagglutinin-antibody titres influence the vaccine response but not necessarily the vaccine effectiveness.
    Lang PO
    Drugs Aging; 2011 Jun; 28(6):505; author reply 505-7. PubMed ID: 21639411
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on influenza vaccine in industry.
    Smith JW; Pollard R
    Postgrad Med J; 1973 Mar; 49(569):169-74. PubMed ID: 4802598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.
    Dikow R; Eckerle I; Ksoll-Rudek D; Hampel H; Schwenger V; Zeier M; Schnitzler P; Sommerer C
    Am J Kidney Dis; 2011 May; 57(5):716-23. PubMed ID: 21349617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Buccaline Berna on absenteeism of an industral population].
    Gubéran E; Schellhorn JP
    Schweiz Rundsch Med Prax; 1972 Jul; 61(27):884-7. PubMed ID: 4680952
    [No Abstract]   [Full Text] [Related]  

  • 8. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
    Baldo V; Baldovin T; Floreani A; Carraro AM; Trivello R;
    Vaccine; 2007 May; 25(20):3955-61. PubMed ID: 17383057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated polyvalent influenza virus vaccine--a controlled study of its efficacy in the prevention of respiratory illness in industrial workers.
    Newman J
    S Afr Med J; 1967 Sep; 41(34):856-8. PubMed ID: 6053879
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of influenza vaccination on civilian aircrew illness and absenteeism.
    Mixéu MA; Vespa GN; Forleo-Neto E; Toniolo-Neto J; Alves PM
    Aviat Space Environ Med; 2002 Sep; 73(9):876-80. PubMed ID: 12234038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to maximize influenza vaccine impact in older adults.
    Whitaker JA; von Itzstein MS; Poland GA
    Vaccine; 2018 Sep; 36(40):5940-5948. PubMed ID: 30153995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A COMPARATIVE TRIAL OF OIL-ADJUVANT AND AQUEOUS POLYVALENT INFLUENZA VACCINES.
    HOWELL RW; MACKENZIE AB
    Br J Ind Med; 1964 Oct; 21(4):265-8. PubMed ID: 14249894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.
    Pierse N; Kelly H; Thompson MG; Bissielo A; Radke S; Huang QS; Baker MG; Turner N;
    Vaccine; 2016 Jan; 34(4):503-509. PubMed ID: 26685091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
    O'Hagan DT
    Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of influenza vaccination for oncology patients.
    Pollyea DA; Brown JM; Horning SJ
    J Clin Oncol; 2010 May; 28(14):2481-90. PubMed ID: 20385981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.
    Fernández-Ruiz M; Lumbreras C; Arrazola MP; López-Medrano F; Andrés A; Morales JM; de Juanes JR; Aguado JM
    Transpl Infect Dis; 2015 Apr; 17(2):314-21. PubMed ID: 25728936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of polyvalent oil-adjuvant influenza vaccine in chdren.
    Quilligan JJ; Baernstein HD
    Pediatrics; 1966 Aug; 38(2):207-10. PubMed ID: 5944155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Protective effect of the domestic oil adjuvant vaccine against influenza (1 year after vaccination)].
    Bervar M; Papo I; Piscević S; Duknić M
    Vojnosanit Pregl; 1971 Oct; 28(10):505-11. PubMed ID: 5134859
    [No Abstract]   [Full Text] [Related]  

  • 19. [Economic and Health impact of influenza vaccination with adjuvant MF59 in population over 64 years in Spain].
    Pérez-Rubio A; Eiros JM
    Rev Esp Quimioter; 2018 Feb; 31(1):43-52. PubMed ID: 29355006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of early alert and of adjuvant in the control of Hong Kong influenza by vaccines.
    Hilleman MR
    Bull World Health Organ; 1969; 41(3):623-8. PubMed ID: 4985377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.